Logo image of GIBO

GIBO HOLDINGS LTD-CL A (GIBO) Stock Fundamental Analysis

USA - NASDAQ:GIBO - KYG386171253 - Common Stock

2.6 USD
0 (0%)
Last: 10/6/2025, 1:04:07 PM
Fundamental Rating

1

GIBO gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 69 industry peers in the Interactive Media & Services industry. GIBO has a bad profitability rating. Also its financial health evaluation is rather negative. GIBO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GIBO was profitable.
In the past year GIBO has reported a negative cash flow from operations.
GIBO Yearly Net Income VS EBIT VS OCF VS FCFGIBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 500K -500K 1M -1M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.66%, GIBO is in the better half of the industry, outperforming 65.22% of the companies in the same industry.
GIBO has a Return On Equity of 4.00%. This is in the better half of the industry: GIBO outperforms 65.22% of its industry peers.
Industry RankSector Rank
ROA 3.66%
ROE 4%
ROIC N/A
ROA(3y)3.73%
ROA(5y)N/A
ROE(3y)96.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GIBO Yearly ROA, ROE, ROICGIBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 50 100 150 200 250

1.3 Margins

GIBO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GIBO Yearly Profit, Operating, Gross MarginsGIBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, GIBO has less shares outstanding
Compared to 1 year ago, GIBO has a worse debt to assets ratio.
GIBO Yearly Shares OutstandingGIBO Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10K 20K 30K
GIBO Yearly Total Debt VS Total AssetsGIBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

GIBO has an Altman-Z score of 1.71. This is a bad value and indicates that GIBO is not financially healthy and even has some risk of bankruptcy.
GIBO has a Altman-Z score of 1.71. This is comparable to the rest of the industry: GIBO outperforms 55.07% of its industry peers.
GIBO has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.05, GIBO perfoms like the industry average, outperforming 57.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 1.71
ROIC/WACCN/A
WACCN/A
GIBO Yearly LT Debt VS Equity VS FCFGIBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 0.01 indicates that GIBO may have some problems paying its short term obligations.
The Current ratio of GIBO (0.01) is worse than 98.55% of its industry peers.
A Quick Ratio of 0.01 indicates that GIBO may have some problems paying its short term obligations.
GIBO has a Quick ratio of 0.01. This is amonst the worse of the industry: GIBO underperforms 98.55% of its industry peers.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
GIBO Yearly Current Assets VS Current LiabilitesGIBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

GIBO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.90%.
EPS 1Y (TTM)-17.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 0.07, the valuation of GIBO can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of GIBO indicates a rather cheap valuation: GIBO is cheaper than 98.55% of the companies listed in the same industry.
GIBO's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.86.
Industry RankSector Rank
PE 0.07
Fwd PE N/A
GIBO Price Earnings VS Forward Price EarningsGIBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GIBO Per share dataGIBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GIBO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GIBO HOLDINGS LTD-CL A

NASDAQ:GIBO (10/6/2025, 1:04:07 PM)

2.6

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.23%
Inst Owner ChangeN/A
Ins Owners1.35%
Ins Owner ChangeN/A
Market Cap9.44M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.07
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.31
P/tB 0.31
EV/EBITDA N/A
EPS(TTM)37.44
EY1440%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0
BVpS8.27
TBVpS8.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.66%
ROE 4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)3.73%
ROA(5y)N/A
ROE(3y)96.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 1.71
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-154.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-228.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-228.48%
OCF growth 3YN/A
OCF growth 5YN/A